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Introduction
Introducing laparoscopy in gynecology during the 1960s
in Europe placed gynecology as pioneer in this less invasive
approach in surgery. At that time, gynecological laparoscopy
was predominantly used in diagnostics by means of direct
visualization of pelvis minor. During the 1970s the gynecolo-
gists shifted the use of endoscopic technology from diagnostic
to surgical purposes such as tubal ligation.  From that time,
laparoscopy has become a leading technique in diagnostics
and surgical treatment of benign lesions in gynecology
 1.  By
using laparoscopy in detection of bladder and prostate carci-
noma spreading into the lymph nodes urologists have become
the pioneers of the use of laparoscopy in the field of oncol-
ogy 
2. During the late 1980s, the initiators of endoscopic on-
cology began with laparoscopic evaluations of the condition
and spreading of the malignant disease. The first reports were
available at the beginning of 1990s, and with them came the
controversial opinions about the usefulness of laparoscopy and
minimal invasive surgery in gynecologic oncology. Disagree-
ments were mainly associated with medicolegal aspects of
possible consequences resulted from inadequate surgical
treatment of malignant diseases.
The trends of laparoscopy use in gynecologic
surgery
There has been an increasing trend in the use of mini-
mal invasive techniques for resection and/or staging of ma-
lignancies in gynecology during the last ten years. Many
studies report the advantages of these procedures, their effi-
cacy, safety and adequacy in surgical treatment of gyneco-
logic malignancies
 3–6. A survey conducted in 2004 and 2007
among the members of the Society of Gynecologic Oncolo-
gist (SGO) in the USA showed a significant increase in the
use of laparoscopy. Forty-six percent of 850 SGO members
responded to the survey. In 2004 survey, laparoscopic sur-
gery was indicated in 84% of cases while in 2007 survey it
was increased to 91%. The following laparoscopic proce-
dures were most often indicated
 7: laparoscopically assisted
vaginal hysterectomy (LAVH) or total laparoscopic hyster-
ectomy (TLH) and staging of endometrial carcinoma (43%);
diagnostics of adnexal masses (39%); prophylactic salpingo-
oophorectomy in case of women at high risk for ovarian can-
cer (11%).
These procedures are accepted as the most convenient
for use in endoscopic surgery. The question regarding the
conversion from laparoscopy to laparotomy was answered by
90% of the survey participants. In 2004, 25% of them did the
conversion, while in 2007 only 3% of conversions were re-
ported by 94% of surveyed SGO members 
7. The mentioned
data and numerous papers published in Europe and Asia
point to the increasing trend of using laparoscopy in gyne-
cologic oncology (Table 1).
The launch of minimally invasive surgery reduces the
operation-induced trauma, provides a faster recovery, short-
ens the hospitalization and lowers the total costs of treat-
ment. The purpose of using laparoscopy in gynecologic sur-
gery is to confirm therapeutic efficacy compared with stan-
dard surgical procedures and to reduce the appearance of
side effects.  Still open are dilemmas regarding the results of
treatment after laparoscopic surgery in oncology and intra-
operative complications such as injuries of intestines, larger
blood vessels and tumor cells dissemination.
Small incisions suitable for ports and laparoscopic in-
struments do not make possible the removal of large solid
tumors. Tearing the tumor into pieces and its rough excision
from pelvis and abdomen may cause spreading and expan-
sion of tumor cells in the abdomen and development of me-
tastases in the area of port incisions. The basic aim of treat-Strana 862 VOJNOSANITETSKI PREGLED Volumen 70, Broj 9
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ment in oncology is the complete removal of malignant tu-
mor and interruption of its spreading, and control and alle-
viation of disease symptoms. If the aim can be achieved by
minimally invasive laparoscopic procedures than their use is
justified but not at any price and if they are harmful to pa-
tients’ health 
8. Nevertheless, laparoscopic surgery in gyne-
cologic oncology has become a standard procedure in the
majority of medical institutions in developed countries.
Modern medical technology, acquired experience, and better
surgical training with modern endoscopy equipment have
been the main reasons for that.
The surgeons have agreed that laparoscopic techniques
are associated with extremely gradual process of learning,
which starts with small and simple procedures and goes up to
more complex and comprehensive laparoscopic operations. It
should be mentioned that laparoscopic operations in gyne-
cologic oncology could be performed only by surgeons who
have already mastered the techniques of classic surgery and
are skilled to manage the complications. The learning curve
starts with classic surgery procedures in gynecologic oncol-
ogy and continues with learning the basics of laparoscopic
operations and skills under supervision. The next step is to
have sufficiently enough training after which come the actual
performance of laparoscopic procedures and operations in
the treatment of gynecologic oncology patients 
8.
The use of robotics in laparoscopy
Robotic assisted surgery is a new aspect in gynecologic
oncology which eliminates the basic ergonomic problem for
a surgeon and the most important long learning curve. In ad-
dition, it gives a 3-D vision and magnification: the surgeon
controls the camera, the image is directly projected, the
movements are intuitive, the instruments are articulated and
ergonomic, the tremor is eliminated. The first surgical robots
were presented during the 1980s. The development of ro-
botic surgery made possible broader applications for surgical
indications. ROBODOC was the first surgical robot ap-
proved by the United States Food and Drug Administration
FDA. The next were Automatic Endoscopic System for Op-
timal Positioning (AESOP) in 1994 and ZEUS, a second-
generation robotic system in 1998 
9. The da Vinci surgical
system is the most sophisticated of the surgical robotic sys-
tems. Based upon the first reports made by Advincula and
Reynolds on the use of robot for myomectomies, FDA ap-
proved the use of the da Vinci in gynecologic procedures in
April 2005 
10–13. At the annual SGO meeting in February
2006, Boggess 
14 did a live demonstration of radical hyster-
ectomy and reported on 13 previously performed operations.
Since then, the use of robotic surgery in gynecologic oncol-
ogy has constantly been improved in world centers.
Laparoscopy in endometrial carcinoma
Laparoscopic approach in treatment of endometrial car-
cinoma implies laparoscopic determination of the stage of
the disease combined with laparoscopically assisted vaginal
(LAVH) or laparoscopic hysterectomy and bilateral ad-
nexectomy. In the initial FIGO stage I of endometrial carci-
noma, which is limited only to the uterus, laparoscopically
assisted vaginal hysterectomy with bilateral adnexectomy
should be applied whenever it is technically possible 
15, 16.
Zullo et al. 
17 conducted a randomized study to compare
laparoscopy vs laparotomy in patients with early stages of
endometrial carcinoma. The authors showed that the safety
and efficiency of laparoscopy was the same as in the open
approach, pointing out the benefit of laparoscopy in relation
to the quality of life during the first 6 months after the sur-
gery.  Tozzi et al. 
18 reported the first results of the survival
of patients with endometrial carcinoma who were operated
laparoscopically in comparison to those patients who under-
went open surgery. Based on the average follow-up of 44
months of patients with endometrial carcinoma FIGO stage I,
they found that a disease-free interval among laparoscopi-
cally operated patients was 91% compared to 94% among
patients treated with classic surgery. Overall survival was
86% compared to 90% in patients with laparotomy. Malur et
al.
 19 presented 70 patients with stage I-III of endometrial
carcinoma: 37 patients had laparoscopically assisted vaginal
hysterectomy and 33 underwent open surgery. Comparative
analysis of the removed lymphatic nodes and duration of
surgery did not show a statistically significant difference.
The recurrence-free interval did not show statistically sig-
nificant difference between the laparoscopy group (97%) and
Table 1
Laparoscopic procedures that are frequently applied in gynecological oncology
Localization of a malignant tumor Type of laparoscopic surgery
Cervix uteri carcinoma
Laparoscopically assisted radical vaginal hysterectomy
(Schauta-Amreich and Schauta-Stoeckel)
Laparoscopically assisted radical vaginal trachelectomy
Laparoscopic radical abdominal hysterectomy
Laparoscopic lymphadenectomy (pelvic and para-aortic)
Laparoscopic evaluation of the stage of the disease
Endometrial carcinoma
Laparoscopic evaluation of the stage of the disease
Laparoscopically assisted vaginal hysterectomy with bilateral
adnexectomy
Laparoscopic hysterectomy with bilateral adnexectomy
Laparoscopic lymphadenectomy  (pelvic and para-aortic)
Ovarian carcinoma Diagnostic laparoscopy
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the laparotomy group (93%). Similar results were presented
in relation to overall survival, 84% in the laparoscopic group,
and 91% in the laparotomy group.
Ju et al. 
20 included 5 prospective and 8 retrospective
studies in a meta-analysis. The comparison of the laparo-
scopic approach to open surgery in endometrial carcinoma
did not confirm a statistically significant difference for the
overall survival and the recurrence of the disease, while the
number of complications was lower in the group with the
laparoscopic approach. Furthermore, the analysis of 5 studies
dealing with the number of lymphatic nodes in tested groups
did not confirm any statistically significant difference. In the
study of Janda et al. 
21, the quality of life after total laparo-
scopic hysterectomy (TLH), n = 190, and total abdominal
hysterectomy (TAH), n = 142, was examined. In the early
phase of the recovery period, the improvement of the quality
of life was more pronounced in patients with TLH. Better
quality of life continued its trend in the TLH group even 6
months after the surgery. Longer duration of the surgery was
statistically significant in the TLH group (138 ± 43 min),
when compared with the TAH group (109 ± 34 min; p =
0.001). Intraoperative complications were similarly present
in both of the groups (TAH 8/142, 5.6%, and TLH 14/190,
7.4%; p = 0.55). During the postoperative period, two times
more adverse events occurred in the TAH group than in the
TLH patients (33/142, 23.2%, and 22/190, 11.6%, respec-
tively; p = 0.004). Serious postoperative complications were
more frequent in the TAH patients (27/142, 19.0%) than in
the TLH group (15/190, 7.9%; p = 0.002). The advantages of
the laparoscopic approach, together with the vaginal hyster-
ectomy imply less percentage of postoperative complica-
tions, shorter recovery period at the hospital, even in the
group of obese patients 
22.
Laparoscopy in cervix uteri carcinoma
Vaginal radical hysterectomy as a method of choice in
the treatment of cervix uteri carcinoma was the initial idea
for performance of the first laparoscopic lymphadenectomy
in the treatment of early invasive cervix uteri carcinoma. The
greatest advantage of the vaginal operative procedure is the
possibility of closure of the cervix at the very beginning of
the surgery and the reduction of chances for tumor dissemi-
nation. Dargent performed the laparoscopic lymphadenec-
tomy after the Schauta’s vaginal radical hysterectomy in
1986 in Lion, and that was the first step of implementation of
laparoscopy in combination with already familiar radical
vaginal surgery. Dargent published the first results after the
surgeries of 51 patients, where a three-year long survival was
registered in 95%.  At the beginning, laparoscopy had extra-
peritoneal approach, but since 1992, Querleu has been pro-
moting a transumbilical transperitoneal laparoscopic dissec-
tion of lymphatic nodes 
23. After more than 10 years of im-
plementation in surgical practice, the analysis showed that
the laparoscopic lymphadenectomy is an equally safe and re-
liable method as laparotomy, with the great advantage of the
minimally invasive approach. Laparoscopic lymphadenec-
tomy can also be performed as a diagnostic procedure in pa-
tients with the early stage of the cervix uteri carcinoma be-
fore making the decision on the selection of the therapeutic
procedure
24, 25. More frequent implementation of laparos-
copy created conditions for performance of laparoscopic
radical abdominal hysterectomy and laparoscopically as-
sisted radical vaginal trachelectomy (LVRT) 
26–29. In 1994,
Daniel Dargent presented the concept of radical vaginal
trachelectomy, where the body of uterus, ovaries, and the
fallopian tubes were preserved and the vaginal approach
radically removed the cervix uteri, the upper third of the va-
gina and a part of parametrium. This procedure is combined
with the laparoscopically assisted lymphadenectomy in an
identical way as in the case of laparoscopically assisted radi-
cal vaginal hysterectomy 
23. These surgeries are reserved
only for the early stages of the cervix uteri carcinoma with
the aim of preservation of the patient’s fertility 
30. Imple-
mentation of laparoscopy in the advanced disease is limited
to lymphadenectomy, which is performed in some centers,
because it was proved that the patients who had their bulky
lymph nodes removed before the therapy had better sur-
vival
 8. Introduction of robotic surgery has also widened the
indication of laparoscopic robotic surgery implementation in
the treatment of cervical carcinoma 
31. Magrina et al. 
32 pre-
sented the comparison of robotic laparoscopic radical hyster-
ectomy with classical laparoscopic approach and laparotomy.
The average durations of robotic procedure, laparoscopy and
laparotomy were 189.6 min, 220.4 min and 166.8 min, re-
spectively, with loss of blood of 133 mL, 208 mL, and 443.6
mL, respectively. The average number of removed lymphatic
nodes was 25.9 in robotic laparoscopy, 25.9 in laparoscopy
and 27.7 in laparotomy with hospital stay of 1.7, 2.4 and 3.6
days, respectively. There were no differences in intra- and
postoperative complications among the tested groups. During
the follow-up of all the three groups in duration of 31.1
months, no disease recurrence was registered 
32.
Laparoscopy in ovarian carcinoma
There is a general consensus that implementation of
laparoscopy as a surgical approach in treatment of benign
adnexal masses is entirely justified due to reduced loss of
blood, shorter hospital stay, less complications and pain and
reduced treatment expenses in comparison to the open ap-
proach
33.
The role of laparoscopy in the treatment of ovarian car-
cinoma remains in the domain of discussion and insuffi-
ciently clear directives. In the majority of cases, laparoscopy
imposed itself as a method of surgical staging of the disease
and deciding on further treatment of ovarian carcinoma.
When compared, the results of laparoscopic surgical
staging, in relation to laparotomy, showed reduced loss of
blood, shorter hospital stay and less complications with
longer operative time. The numbers of lymphatic glands and
survival were not significantly statistically different 
34, 35.
However, there are pending questions related to imple-
mentation of laparoscopy, and now even robotic laparos-
copy, in cytoreductive surgery of the advanced ovarian car-
cinoma, which is still diagnosed in about 75% of cases.Strana 864 VOJNOSANITETSKI PREGLED Volumen 70, Broj 9
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Conclusion
Implementation of laparoscopy, ie minimally invasive
surgery (MIS) in gynecological oncology represents today a
significant therapeutic modality of treatment without com-
promising basic oncological principles. Using such a medical
technology in oncology patients in Serbia imposes discussion
on a new approach in education and organization of centers
with adequate equipment where this type of surgery could be
implemented with a sufficient number of cases.
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